XXXVI Congreso SETH

XXXVI Congreso Nacional de la Sociedad Española de Trombosis y Hemostasia 36 10. Santos CY, Snyder PJ, Wu WC, et al. Pathophysiologic relationship between Alzheimer’s disease, cerebrovascular disease, and cardiovas- cular risk: a review and synthesis. Alzheimers Dement 2017;7:69-87. 11. Lip G, Freedman B, De Caterina R, et al. Stroke prevention in atrial fibrillation: Past, present and future. Comparing the guidelines and practical decision-making. Thrombosis Haemostasis 2017;117:1230-9. 12. Kalantarian S, Stern TA, Mansour M, et al. Cognitive impairment associated with atrial fibrillation: a meta-analysis. Ann Intern Med 2013;158(5):338-46. 13. Ding M, Qiu Ch. Atrial fibrillation, cognitive decline and dementia: an epidemiological review. Curr Epidemiol Rep 2018;5:522-61. 14. Diener HC, Hart R, Koudstaal P, et al. Atrial fibrillation and cognitive function. J Am Coll Cardiol 2019;73(5)612-9. 15. Madhavan M, Hu TY, Gersh BJ, et al. Efficacy of WarfarinAnticoagu- lation and Incident Dementia in a Community-Based Cohort of Atrial Fibrillation. Mayo Clin Proc 2018;93:145-54. 16. An SJ, Kim TJ, Yoon BW. Epidemiology, Risk Factors, and Cli- nical Features of Intracerebral Hemorrhage: An Update. J Stroke 2017;19(1):3-10. 17. DeSimone Ch, Graff-Radford J, El-Harasis M, et al. Cerebral Amyloid Angiopathy. Diagnosis, Clinical Implications, and Management Stra- tegies in Atrial Fibrillation. J Am Col Cardiol 2017;70(9):1173-82. 18. Cannistraro RJ, Meschia JF. The Clinical Dilemma of Anticoagulation Use in Patients with Cerebral Amyloid Angiopathy and Atrial Fibri- llation. Currenat Cardiol Reports 2018;20:106. 19. Schäfer A, Flierl U, Berliner D, et al. Anticoagulants for Stroke Pre- vention inAtrial Fibrillation in Elderly Patients. Cardiovascular Drugs and Therapy. DOI: 10.1007/s10557-020-06981-3 20. Polikandrioti M, Koutelekos I, Vasilopoulos G, et al. Anxiety and Depression in Patients with Permanent Atrial Fibrillation: Prevalence and Associated Factors. Cardiol Res Pract 2018.19;740812. 21. Michal M, Prochaska JH, Ullmann A, et al. Relevance of depression for anticoagulation management in a routine medical care setting: results from theThrombEVAL study program. JThrombHaemost 2014;12(12):2024-33.